Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone help silence distressing voices? online self-help program tested for psychosis

NCT ID NCT06186570

Symptom relief Sponsor: Charite University, Berlin, Germany Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests whether a 6-week online self-help program can help people with psychotic disorders who hear voices at least once a week. The program combines metacognitive training and mindfulness techniques to reduce the frequency and distress of auditory hallucinations. Participants are randomly assigned to either the online program or a waitlist while continuing their usual treatment. The goal is to see if this digital tool improves how people cope with voices and their overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Online-based self-help intervention combining metacognitive training and mindfulness
What this could lead to
If effective, this could offer a low-cost, accessible way for people with psychosis to better manage distressing voices from home.
What could go wrong
This is a small early-stage trial with 86 participants, and the intervention is self-guided online, so results may not apply to everyone or replace standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

86 people

The number who actually took part.

Started

Jun 2024

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * current experience of auditory hallucinations that appear at least once a week (measured over the PSYRATS). * diagnosis of a schizophrenia-spectrum disorder according to the Diagnostical and Statistical Manual (5th edition) and/or the International Statistical Classification of Diseases and Related Health Problems (ICD-10), code F2x.x. In case of a suspected diagnosis or missing clinical diagnostic, we will apply the Mini-International Neuropsychiatric Interview (M.I.N.I.). * stable psychiatric medication over at least one month, slight changes of dosage are allowed and will be evaluated by a trained psychiatrist. * ability to give informed consent. * willingness and ability to engage in the psychotherapeutic self-help intervention. * availability of a mobile device and internet access. Exclusion Criteria: * neurological disorders that may affect cognitive functioning and condition after severe traumatic brain injury. * acute suicidality, assessed at the previous screening procedures. * auditory hallucinations in the context of other primary diagnoses e.g., post-traumatic stress disorder or borderline personality disorder. * acute substance abuse other than nicotine and prescribed medication. * current electroconvulsive therapy. * current inpatient or day-care treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Psychotic disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hallucinations psychotic disorder Psychotic Disorders schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Psychotic disorders

Contacts and locations

Locations

  • Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin

    Berlin, State of Berlin, 12203, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.